PUBLICATIONS
Lab of Molecular and Digital Pathology for Theranostics
> PUBLICATIONS > Publications
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase
김민기
2018-07-30
조회수 386
제목 : Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.
저널 : J Clin Oncol
연권호 : 2018 Jun 15:JCO2017773184. doi: 10.1200/JCO.2017.77.3184. [Epub ahead of print]
Lab of Molecular and Digital Pathology for
Theranostics SAIHST, Sungkyunkwan University
Copyright © CGMP. All rights reserved.
